Lundbeck presents Phase Ib data for Lu AF28996 in advanced Parkinson's disease, as Phase II trial begins
PR Newswire
AppLovin Corporation (NASDAQ:APP) Receives Average Rating of "Moderate Buy" from Brokerages
MarketBeat
Wingstop Inc. (NASDAQ:WING) Receives Average Recommendation of "Moderate Buy" from Brokerages
MarketBeat


